Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-01-25

Clinical Trial Update: Enhanced Medication Reconciliation For Serious Mental Illness [NA]

View source ↗

Summary

The clinical trial investigating enhanced medication reconciliation for serious mental illness has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Precera Bioscience, Inc. | Conditions: Mental Disorders | NA | Status: TERMINATED